UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Review Which Crypto Strategies Are Low Risk, focusing on capital preservation, diversification, and disciplined rebalancing.
27,978 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
York Space Systems stock tumbled after a disappointing quarterly report. This guide explains what happened, why it ma...
Nvidia stands at a crossroads as it prepares to report Feb earnings. This article unpacks why the result could redefi...
As growth ETFs pivot in 2026, the case for a tighter mega-cap tilt strengthens. This analysis weighs performance, con...
A little-known rival to SCHD has delivered competitive long-run gains and steady monthly income, thanks to a mid-cap ...
Zoom stock jumped today as investors priced in AI-driven growth and expanding enterprise traction. This article break...
Oil prices remain a key driver for energy stocks. This article highlights three dividend-friendly picks—Chevron, Exxo...
What looked like a cautious second quarter instead became a showcase of corporate resilience. This piece breaks down ...
In a landscape defined by budget cycles and rapid tech shifts, L3Harris Technologies stands out with a 7.1 rating in ...
Dell shares surged to a new all-time high after a blockbuster earnings report. This article breaks down the why, what...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
This article breaks down APi Group's Q1 2026 earnings call, translating the numbers into actionable takeaways for inv...